Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA

dc.contributor.authorEarnest, Rebecca
dc.contributor.authorUddin, Rockib
dc.contributor.authorMatluk, Nicholas
dc.contributor.authorRenzette, Nicholas
dc.contributor.authorTurbett, Sarah E.
dc.contributor.authorSiddle, Katherine J.
dc.contributor.authorLoreth, Christine
dc.contributor.authorAdams, Gordon
dc.contributor.authorTomkins-Tinch, Christopher H.
dc.contributor.authorPetrone, Mary E.
dc.contributor.authorRothman, Jessica E.
dc.contributor.authorBreban I, Mallery
dc.contributor.authorKoch, Robert Tobias
dc.contributor.authorBillig, Kendall
dc.contributor.authorFauver, Joseph R.
dc.contributor.authorVogels, Chantal B. F.
dc.contributor.authorBilguvar, Kaya
dc.contributor.authorDe Kumar, Bony
dc.contributor.authorLandry, Marie L.
dc.contributor.authorPeaper, David R.
dc.contributor.authorKelly, Kevin
dc.contributor.authorOmerza, Greg
dc.contributor.authorGrieser, Heather
dc.contributor.authorMeak, Sim
dc.contributor.authorMartha, John
dc.contributor.authorDewey, Hannah B.
dc.contributor.authorKales, Susan
dc.contributor.authorBerenzy, Daniel
dc.contributor.authorCarpenter-Azevedo, Kristin
dc.contributor.authorKing, Ewa
dc.contributor.authorHuard, Richard C.
dc.contributor.authorNovitsky, Vlad
dc.contributor.authorHowison, Mark
dc.contributor.authorDarpolor, Josephine
dc.contributor.authorManne, Akarsh
dc.contributor.authorKantor, Rami
dc.contributor.authorSmole, Sandra C.
dc.contributor.authorBrown, Catherine M.
dc.contributor.authorFink, Timelia
dc.contributor.authorLang, Andrew S.
dc.contributor.authorGallagher, Glen R.
dc.contributor.authorPitzer, Virginia E.
dc.contributor.authorSabeti, Pardis C.
dc.contributor.authorGabriel, Stacey
dc.contributor.authorMacInnis, Bronwyn L.
dc.contributor.authorTewhey, Ryan
dc.contributor.authorAdams, Mark D.
dc.contributor.authorPark, Daniel J.
dc.contributor.authorLemieux, Jacob E.
dc.contributor.authorGrubaugh, Nathan D.
dc.contributor.authorTeam, New England Variant Invest
dc.date.accessioned2023-02-21T12:41:50Z
dc.date.available2023-02-21T12:41:50Z
dc.date.issued2022-01-01
dc.description.abstractThe SARS-CoV-2 Delta variant rose to dominance in mid-2021, likely propelled by an estimated 40\%???80\% increased transmissibility over Alpha. To investigate if this ostensible difference in transmissibility is uniform across populations, we partner with public health programs from all six states in New England in the United States. We compare logistic growth rates during each variant???s respective emergence period, finding that Delta emerged 1.37???2.63 times faster than Alpha (range across states). We compute variant-specific effective reproductive numbers, estimating that Delta is 63\%???167\% more transmissible than Alpha (range across states). Finally, we estimate that Delta infections generate on average 6.2 (95\% CI 3.1???10.9) times more viral RNA copies per milliliter than Alpha infections during their respective emergence. Overall, our evidence suggests that Delta???s enhanced transmissibility can be attributed to its innate ability to increase infectiousness, but its epidemiological dynamics may vary depending on underlying population attributes and sequencing data availability.
dc.description.issue4
dc.description.issueAPR 19
dc.description.volume3
dc.identifier.doi10.1016/j.xcrm.2022.100583
dc.identifier.urihttps://hdl.handle.net/11443/2757
dc.identifier.urihttp://dx.doi.org/10.1016/j.xcrm.2022.100583
dc.identifier.wosWOS:000838714200024
dc.publisherELSEVIER
dc.relation.ispartofCELL REPORTS MEDICINE
dc.titleComparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA
dc.typeArticle

Files

Collections